California State Teachers Retirement System (CalSTRS)’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ZVRA
WP
NCM
VCM
ACM
California State Teachers Retirement System (CalSTRS)'s ZVRA Position: Q1 2026 in Review
California State Teachers Retirement System (CalSTRS) increased its Zevra Therapeutics (ZVRA) stake by 2.1% in Q1 2026, buying an estimated $559 and bringing the position to 3,015 shares worth $28.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2325.
California State Teachers Retirement System (CalSTRS) first reported a position in ZVRA in Q2 2021 and has held it in 16 quarters since. The position peaked at $505K in Q2 2021. 148 funds tracked by Wall St. Rank hold ZVRA as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) held 3,015 shares of Zevra Therapeutics worth $28.1K as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) bought 62 Zevra Therapeutics shares in Q1 2026, an estimated $559.
- Zevra Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2325 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in Zevra Therapeutics in Q2 2021 and has held it in 16 quarters since.
- California State Teachers Retirement System (CalSTRS)'s Zevra Therapeutics position peaked at $505K in Q2 2021.
- 148 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q1 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.